# Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

> **NCT02286895** · PHASE4 · COMPLETED · sponsor: **PATH** · enrollment: 600 (actual)

## Conditions studied

- Diarrhea Rotavirus

## Interventions

- **BIOLOGICAL:** pentavalent rotavirus vaccine (PRV)
- **BIOLOGICAL:** measles vaccine (MV)
- **BIOLOGICAL:** yellow fever vaccine (YFV)
- **BIOLOGICAL:** meningitis conjugate vaccine (PsA-TT-5μg)

## Key facts

- **NCT ID:** NCT02286895
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2019-01-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02286895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02286895, "Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02286895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*